Panbela Therapeutics Inc (PBLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Operating Expenses | 25,647 | 34,093 | 10,010 | 5,754 | 4,322 |
| Operating Income | -25,647 | -34,093 | -10,010 | -5,754 | -4,322 |
| Interest Expense | 317 | 288 | 12 | 17 | 2,194 |
| Other Income | 515 | -668 | -601 | 708 | -99 |
| Pre-tax Income | -25,449 | -35,049 | -10,623 | -5,063 | -6,615 |
| Income Tax | -186 | -116 | -488 | -295 | -415 |
| Net Income Continuous | -25,263 | -34,933 | -10,135 | -4,768 | -6,200 |
| Net Income | $-25,263 | $-34,933 | $-10,135 | $-4,768 | $-6,200 |
| EPS Basic Total Ops | -316.52 | -41,341.21 | -20,804.80 | -14,894.89 | -26,186.18 |
| EPS Basic Continuous Ops | -231.77 | -41,340.83 | -20,775.04 | -14,812.69 | -26,131.39 |
| EPS Diluted Total Ops | -316.52 | -41,341.21 | -20,804.80 | -14,894.89 | -26,186.18 |
| EPS Diluted Continuous Ops | -231.77 | -41,340.83 | -20,775.04 | -14,812.69 | -26,131.39 |
| EPS Diluted Before Non-Recurring Items | -316.52 | -40,786.79 | -20,900.90 | -14,894.89 | N/A |
| EBITDA(a) | $-25,647 | $-34,093 | $-10,010 | $-5,754 | $-2,244 |